Galleri by GRAIL vs Oncotype DX
Side-by-side comparison of cancer screening tests.
← Back to Cancer Screening
Test Performance
| Feature | Galleri by GRAIL | Oncotype DX |
|---|---|---|
| Price | $949 | Variable |
| Cancers Detected | 50+ cancers | Breast recurrence risk |
| Sensitivity | 51.5% overall | N/A |
| Specificity | 99.5% | N/A |
| Sample Type | Blood draw | Tumor tissue |
| FDA Status | Not FDA approved | Guideline recommended |